久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China's influence on global oncology community hailed

By Zhou Wenting in?Shanghai | chinadaily.com.cn | Updated: 2023-12-19 17:00
Share
Share - WeChat
Han Baohui, honorary director of the department of respiratory medicine at Shanghai Chest Hospital Affiliated with Shanghai Jiao Tong University School of Medicine. [Photo provided to chinadaily.com.cn]

China's voice in the international oncology community is growing, and its innovations in lung cancer diagnosis and treatment have also benefited the world, said a leading domestic expert of lung cancer during an event held by ClinChoice in Shanghai on Dec 16.

Since 20 years ago, when China caught up with the boom of targeted therapy in the field of lung cancer, the country has experienced rapid development and has now become a leader in the world's second echelon of research in this realm, said Han Baohui, honorary director of the department of respiratory medicine at Shanghai Chest Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, during the event which hosted discussions about the research and development of innovative medicines.

"In terms of all the drug targets, China has far exceeded the European Union and Japan in the number of studies and papers, and is only second to the United States," he said.

Han pointed out that China has also taken the lead in the development of immunotherapy, an innovative oncology treatment method.

"China has approved 10 immunotherapy products for cancer treatment, including four imported and six homegrown ones, welcoming advanced treatments at an accelerated pace," he explained. "Also, some immunotherapy products from China have been approved and marketed in the US and Europe, benefiting many other patients besides those in China. For example, immunotherapy products by Chinese biotech companies such as Beigene and Junshi Biosciences have already been marketed in Europe and the US respectively in recent months."

Han noted that China's strength in oncology research is significant because this means Asian populations are better represented in global multicenter research programs.

Han then said he hopes to see some changes in the design of clinical research of new medicines. He explained that under current research requirements, only patients who meet certain criteria are included in a clinical study. As such, researchers should expand the scope as well as establish a subgroup of participants.

"Once a drug is marketed, various complex situations will arise. For example, some patients have lung cancer as well as severe chronic obstructive pulmonary disease (COPD) or diabetes, and doctors still have to do everything possible to treat them," said Han.

"The data obtained from this subgroup will greatly help guide physicians in terms of medication use after the new drug is marketed."

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲午夜久久久久国产 | 青草久草| 亚洲加勒比在线 | 九九99| 久久国产成人精品国产成人亚洲 | 中国三级网站 | 国内精自品线一区91 | 欧美一级片在线 | 亚洲国产精品激情在线观看 | 日韩免费观看一级毛片看看 | 亚洲国产精品a一区二区三区 | 亚洲欧美日韩精品久久亚洲区 | 色悠久久久久综合网伊人男男 | 中文字幕在线观看亚洲日韩 | 欧美一级欧美一级在线播放 | 欧美一级成人 | 成人永久免费视频网站在线观看 | 国产精品国产国产aⅴ | 国产精品亚洲欧美日韩一区在线 | 免费一级片网站 | 国产一区二区三区免费在线观看 | 色综合亚洲七七久久桃花影院 | 久久在线影院 | 成年女人毛片免费播放视频m | 久久久91精品国产一区二区 | 99精品在线视频观看 | 女人张开腿让男人捅爽 | 日产日韩亚洲欧美综合搜索 | 精品一区二区三区18 | 亚洲欧洲一区二区 | 欧美另类视频一区二区三区 | 免费a网址| 日韩三级黄 | 日本一区二区在线 | 免费观看欧美一级毛片 | 色视频网站大全免费 | 精品精品国产自在久久高清 | 国产精品性视频免费播放 | 国产一级二级三级视频 | 精品中文字幕不卡在线视频 | 欧美激情综合亚洲一二区 |